Mirati Therapeutics, Inc.
$58.70
+0.00 (+0.00%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +0.0%
- 3 Months
- +0.0%
- YTD
- +0.0%
- 1 Year
- +44.4%
- 3 Year annualized
- +1.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 47.7%
- Largest decline max drawdown, since Oct 2021
- -85.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.96
Own MRTX?
See how MRTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.